MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Access to rehabilitation therapy for people with Parkinson’s disease in Rome, Italy

    G. Di Lazzaro, D. Genovese, AT. Cimmino, P. Zinzi, AR. Bentivoglio, P. Calabresi (Rome, Italy)

    Objective: This survey aimed to evaluate patients’ awareness of healthcare roles, access to care, and use of rehabilitation services in the Rome region, Italy. Background:…
  • 2026 International Congress

    Systemic antioxidant response to bilateral anodal transcranial direct current stimulation in Parkinson’s disease: findings from a pilot randomized controlled study

    H. Hadoush, A. Al-Sharman, S. Banihani (Sharjah, United Arab Emirates)

    Objective: To investigate whether repeated sessions of bilateral anodal tDCS can influence circulating antioxidant enzyme levels and fatigue severity in individuals with Parkinson’s disease. Background:…
  • 2026 International Congress

    Head Trauma History and Motor Phenotype in Early Parkinson’s Disease

    HL. Lee, SM. Choi (Gwangju, Republic of Korea)

    Objective: To examine whether patients with Parkinson's disease (PD) and a history of head trauma (HT) differ from those without HT in terms of motor…
  • 2026 International Congress

    Challenging Traditional Paradigm: Clinical Outcomes of Early vs Late Subthalamic Deep Brain Stimulation in Parkinson’s Disease

    BC. Ari, M. Cakmak, Y. Ekmis, E. Adiguzel, N. Helvaci Yilmaz, Y. Samanci, G. Kenangil, A. Lozano, A. Zirh (Istanbul, Turkey)

    Objective: Deep brain stimulation(DBS) of subthalamic nucleus(STN) is an established treatment for Parkinson’s disease(PD). DBS has been reserved for patients with long-standing disease and disabling…
  • 2026 International Congress

    Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1-associated Parkinson’s Disease

    E. Asimakidou, M. Avenali, J. O. Aasly, M. Afshari, R. Alcalay, S. Anderson, CA. Artusi, B. Bernard, M. Bozzali, S. Bressman, G. Calandra-Buonaura, F. Cavallieri, R. Cilia, JC. Corvol, A. Cocco, RMA. de Bie, D. Ehrlich, R. Eleopra, G. Pal, EM. Valente (Cambridge, United Kingdom)

    Objective: This study focuses on the timing of DBS in relation to PD onset and explores cognitive trajectories across different GBA1 variant classes, with a…
  • 2026 International Congress

    SNCA-Targeting RNAi Therapeutics Prevent Disease Progression in a Synucleinopathy Mouse Model and Enable Robust, Prolonged, and Safe Alpha-Synuclein Protein Reduction in the Cynomolgus Monkey Central Nervous System

    P. Aimé-Wilson, N. Keating, C. Galligan, C. Brown, M. Gao, P. Mookherjee, S. Godin, J. Dave, M. Retter, A. Castoreno, K. Brown, M. Ahmed, A. Avbersek, C. Kyratsous (Tarrytown, USA)

    Objective: Assess the nonclinical efficacy and safety of C16-conjugated siRNAs targeting SNCA mRNA (SNCA siRNA). Background: Parkinson’s disease is a neurodegenerative disorder with an estimated…
  • 2026 International Congress

    Investigating Subthalamic Neuronal Activity in Parkinsonian Patients with Hemidystonia

    P. Pavlovsky, A. Golik, A. Gamaleya, A. Tomskiy, A. Sedov, E. Belova (Moscow, Russian Federation)

    Objective: In this study we aimed to investigate differences in the subthalamic nucleus (STN) activity in Parkinson’s disease (PD) patients who developed hemidystonia. Background: STN…
  • 2026 International Congress

    Recruitment Strategies in a Diverse Parkinson’s Disease Cohort: Lessons from the East London Parkinson’s Disease Project

    KC. Dey, E. Bhadra, A. Zirra, E. Camboe, V. Azoidou, D. Gallagher, T. Boyle, C. Budu, S. Hussain-Ali, CR. Marshall, LJ. Smith, AJ. Noyce (London, United Kingdom)

    Objective: To describe and evaluate recruitment strategies implemented in the East London Parkinson’s Disease (ELPD) Project that were designed to enhance engagement and participation among diverse communities in…
  • 2026 International Congress

    EAGLE: Protocol for a Phase 3 Study to Evaluate the Efficacy and Safety of Two Mobile Applications Combined with Immediate-Release CD/LD for the Management of Idiopathic Parkinson’s Disease

    S. Oren, A. Amedi, S. Molcho, D. Ziv, O. Shoval, S. Erlich (Ramat Gan, Israel)

    Objective: To evaluate the efficacy and safety of Hybridopa A and Hybridopa B, combination products of immediate-release carbidopa/levodopa (IR CD/LD) and therapeutic mobile applications, in adults with idiopathic Parkinson’s disease (PD) on a…
  • 2026 International Congress

    Levodopa dosing regimen influences repetitive tongue force maintenance in Parkinson’s disease

    S. Hayasaka, K. Hatori, K. Sato, T. Ogawa, T. Hatano, T. Fujiwara (Urayasu, Japan)

    Objective: To investigate whether levodopa (LD) dosing regimen influences the dynamics of repetitive maximal tongue pressure (MTP) in patients with Parkinson’s disease (PD). Background: Reduced…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley